Loading clinical trials...
Loading clinical trials...
Retinoblastoma is the most frequent intraocular tumor in children and represents 6% of all pediatric cancers before the age of 5 years-old. The outcome is now excellent with 95 to 97% of 5-years survi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT04959097 · Retinoblastoma, Retinoblastoma Bilateral, and more
NCT06679634 · Retinoblastoma
NCT06424301 · Retinoblastoma, Refractory
NCT06972602 · Retinoblastoma, Retinoblastoma, Recurrent
Fondation A De Rothschild
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions